New Patch for Treatment of Dementia associated with Alzheimer’s Disease
Dementia is a broad term for a group of symptoms including difficulties with memory, language, problem-solving, and other thinking skills. There are many causes of dementia, but the most common cause is Alzheimer’s Disease (AD), making up about 60-80% of cases....
FDA Approves First Generic Symbicort Inhaler
On March 15th, 2022, the FDA announced that a generic for the brand name inhaler Symbicort was approved for use in the United States. This marks a huge step forward in making inhalers for people with asthma or Chronic Obstructive Pulmonary Disease (COPD) more...
Restasis for Dry Eyes – Finally Generic!
Restasis (Cyclosporine Ophthalmic Emulsion) 0.05% was released by Allergan in 2003 for the treatment of dry eye disease. For the last 20 years, Restasis has been available as brand name only, until now. In February 2022, the FDA approved the first generic version of...
New Injectable Medication to Treat Severe Asthma
Asthma Background Asthma is a respiratory health condition that ranges from mild to serious for those who suffer from it. Those with asthma experience narrowing and swelling of their airways, which can make it difficult to breath. This may lead to symptoms of...
